- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about ABT
Recent news which mentions ABT
Abbott Laboratories Is the Latest Company to Get Involved in the Weight Loss Market. Here's How.
February 11, 2024
Tickers
ABT
From Motley Fool
3 Groundbreaking Healthcare Stocks to Buy for Robust Gains
February 11, 2024
From InvestorPlace
These 2 Stocks Are Trying to Ride the Ozempic Bandwagon: Are They Buys?
February 09, 2024
From Motley Fool
7 Tremendous Dividend Stocks With Double-Digit 5-Year Growth Rates
February 07, 2024
From InvestorPlace
From Motley Fool
2 Stocks to Buy Near Their 52-Week Highs
February 05, 2024
From Motley Fool
2 Healthcare Dividend Kings to Buy and Hold Forever
February 04, 2024
From Motley Fool
Could Abbott Labs Be the Next Big Winner in the Billion-Dollar Weight Loss Market?
February 02, 2024
Tickers
ABT
From Motley Fool
Looking At Abbott Laboratories's Recent Unusual Options Activity
January 30, 2024
Tickers
ABT
From Benzinga
7 ‘AgeTech’ Stocks to Profit From the Booming Longevity Market
January 28, 2024
From InvestorPlace
World's Smallest Brain Stimulation Device For Movement Disorder: FDA Approved Abbott's Liberta RC DBS system
January 25, 2024
From Benzinga
Stock Market Extends Record Highs, S&P 500 Hits 4,900 On Tech Rally, Microsoft's $3 Trillion Mark: What's Driving Markets Wednesday?
January 24, 2024
From Benzinga
Abbott Laboratories (ABT) Q4 2023 Earnings Call Transcript
January 24, 2024
Tickers
ABT
From Motley Fool
Abbott Laboratories Surpasses Q4 Sales Expectations, Despite Dip In COVID-19 Testing Demand
January 24, 2024
From Benzinga
Nasdaq, S&P 500 Futures Jump As Wall Street Eagerly Awaits Tesla's Q4 Earnings: Analyst Says Rally Broadening But Favors These Stocks
January 24, 2024
From Benzinga
Earnings Scheduled For January 24, 2024
January 24, 2024
From Benzinga
Investor Optimism Improves Following Earnings Reports; S&P 500 Reaches Another High
January 24, 2024
From Benzinga
Netflix, Tesla And 3 Stocks To Watch Heading Into Wednesday
January 24, 2024
From Benzinga
Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: Analyst
January 23, 2024
From Benzinga
7 Safe-Haven Stocks to Protect Your Portfolio During a Recession
January 23, 2024
From InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
January 23, 2024
From Benzinga
S&P 500, Nasdaq, Dow Jones Strike All-Time Highs Ahead Of Key Earnings This Week: What's Driving Markets Monday?
January 22, 2024
From Benzinga
Tesla, Netflix, Intel Take Center Stage In Pivotal Q4 Earnings Week As S&P 500 Eyes Breaking New Highs
January 22, 2024
From Benzinga
My 5 Top Dividend Stocks to Buy Hand Over Fist in 2024
January 21, 2024
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.